1. Westfall, JM, Lowe, MJ, Fagnan, L. Practice-based research-“blue highways” on the NIH roadmap. JAMA. 2007;297(4):403-406.
Google Scholar | Crossref | Medline | ISI2. Al Diffalha, S, Sexton, KC, Watson, PH, Grizzle, WE. The importance of human tissue bioresources in advancing biomedical research. Biopreserv Biobank. 2019;17(3):209-212.
Google Scholar | Crossref | Medline3. Coppola, L, Cianflone, A, Grimaldi, AM, et al. Biobanking in health care: evolution and future directions. J Transl Med. 2019;17(1):172.
Google Scholar | Crossref | Medline4. Rush, A, Matzke, L, Cooper, S, Gedye, C, Byrne, JA, Watson, PH. Research perspective on utilizing and valuing tumor biobanks. Biopreserv Biobank. 2019;17(3):219-229.
Google Scholar | Crossref | Medline5. Hewitt, RE. Biobanking: the foundation of personalized medicine. Curr Opin Oncol. 2011;23(1):112-119.
Google Scholar | Crossref | Medline6. Matzke, LA, Watson, PH. Biobanking for cancer biomarker research: issues and solutions. Biomarker Insights. 2020;15:1177271920965522.
Google Scholar | SAGE Journals7. Liu, A, Pollard, K. Biobanking for personalized medicine. In: Karimi-Busheri, F , ed. Biobanking in the 21st Centruy. Advances in Experimental Medicine and Biology. Vol. 864. Springer; 2015.
Google Scholar | Crossref8. Castillo-Pelayo, T, Babinszky, S, LeBlanc, J, Watson, PH. The importance of biobanking in cancer research. Biopreserv Biobank. 2015;13(3):172-177.
Google Scholar | Crossref | Medline9. Grizzle, WE, Sexton, KC. Commentary on improving biospecimen utilization by classic biobanks: identifying past and minimizing future mistakes. Biopreserv Biobank. 2019;17(3):243-247.
Google Scholar | Crossref | Medline10. Gaffney, EF, Riegman, PH, Grizzle, WE, Watson, PH. Factors that drive the increasing use of FFPE tissue in basic and translational cancer research. Biotech Histochem. 2018;93(5):373-386.
Google Scholar | Crossref | Medline11. Tsang, HF, Xue, VW, Koh, SP, Po-Wah, L, Wong, SC. Nanostring, a novel digital color-coded barcode technology: current and future applications in molecular diagnostics. Expert Rev Mol Diagn. 2017;17(1):95-103.
Google Scholar | Crossref | Medline12. OpenSpecimen . https://www.openspecimen.org/
Google Scholar13. Vo, K, Jonnagaddala, J, Liaw, ST. Statistical supervised meta-ensemble algorithm for medical record linkage. J Biomed Inform. 2019;95:103220.
Google Scholar | Crossref | Medline14. Chen, A, Jonnagaddala, J, Nekkantti, C, Liaw, ST. Generation of surrogates for de-identification of electronic health records. Stud Health Technol Inform. 2019;264:70-73.
Google Scholar | Medline15. Ng, W, Meagher, N, Shirley, E, et al. Multi-institutional mapping of a biobanking data set to data sources from electronic medical records (eMR) across hospitals in NSW Australia. Poster presented at: international society of biological and environmental respositories (ISBER) meeting, Dallas, TX, May 2018. Biopreserv Biobank. 2018;16(3):A-47.
Google Scholar16. Paradiso, AV, Daidone, MG, Canzonieri, V, Zito, A. Biobanks and scientists: supply and demand. J Transl Med. 2018;16(1):136.
Google Scholar | Crossref | Medline17. Bledsoe, MJ, Sexton, KC. Ensuring effective utilization of biospecimens: design, marketing, and other important approaches. Biopreserv Biobank. 2019;17(3):248-257.
Google Scholar | Crossref | Medline18. Grizzle, WE, Bledsoe, MJ, Al Diffalha, S, Otali, D, Sexton, KC. The utilization of biospecimens: impact of the choice of biobanking model. Biopreserv Biobank. 2019;17(3):230-242.
Google Scholar | Crossref | Medline19. Cadigan, RJ, Juengst, E, David, A, Henderson, G. Underutilization of specimens in biobanks: an ethical as well as practical concern? Genet Med. 2014;16(10):738-740.
Google Scholar | Crossref | Medline20. Watson, PH, Nussbeck, SY, Carter, C, et al. A framework for biobank sustainability. Biopreserv Biobank. 2014;12(1):60-68.
Google Scholar | Crossref | Medline21. Hartman, V, Matzke, L, Watson, PH. Biospecimen complexity and the evolution of biobanks. Biopreserv Biobank. 2019;17(3):264-270.
Google Scholar | Crossref | Medline22. Deveraux, L, Watson, PH, Mes-Masson, AM, et al. A review of international biobanks and networks: success factors and key benchmarks - a 10 year retrospective review. Biopreserv Biobank. 2019;17(6):512-519.
Google Scholar | Crossref | Medline23. Lommen, KOS, de Theije, CC, Smits, KM. Biobanking in molecular biomarker research for the early detection of cancer. Cancers. 2020;12:776.
Google Scholar | Crossref24. Simeon-Dubach, D, Watson, P. Biobanking 3.0: evidence based and customer focused biobanking. Clin Biochem. 2014;47(4-5):300-308.
Google Scholar | Crossref | Medline25. Macheiner, T, Huppertz, B, Bayer, M, Sargsyan, K. Challenges and driving forces for business plans in biobanking. Biopreserv Biobank. 2017;15(2):121-125.
Google Scholar | Crossref | Medline26. Henry, CE, Emmanuel, C, Lambie, N, et al. Distinct patterns of stromal and tumor expression of ROR1 and ROR2 in histological subtypes of epithelial ovarian cancer. Transl Oncol. 2017;10(3):346-356.
Google Scholar | Crossref | Medline27. Henry, CE, Llamosas, E, Daniels, B, Coopes, A, Tang, K, Ford, CE. ROR1 and ROR2 play distinct and opposing roles in endometrial cancer. Gynecol Oncol. 2018;148(3):576-584.
Google Scholar | Crossref | Medline28. Udugama, M, Sanij, E, Voon, HPJ, et al. Ribosomal DNA copy loss and repeat instability in ATRX-mutated cancers. Proc Natl Acad Sci USA. 2018;115(18):4737-4742.
Google Scholar | Crossref | Medline29. Meagher, NS, Wang, L, Rambau, PF, et al. A combination of the immunohistochemical markers CK7 and SATB2 is highly sensitive and specific for distinguishing primary ovarian mucinous tumors from colorectal and appendiceal metastases. Mod Pathol. 2019;32(12):1834-1846.
Google Scholar | Crossref | Medline30. Lawrence, E, Sims, J, Gander, A, et al. The barriers and motivators to using human tissues for research: the views of UK-based biomedical researchers. Biopreserv Biobank. 2020;18(4):266-273.
Google Scholar | Crossref | Medline31. Centenera, MM, Raj, GV, Knudsen, KE, Tilley, WD, Butler, LM. Ex vivo culture of human prostate tissue and drug development. Nat Rev Urol. 2013;10(8):483-487.
Google Scholar | Crossref | Medline32. Broutier, L, Andersson-Rolf, A, Hindley, CJ, et al. Culture and establishment of self-renewing human and mouse adult liver and pancreas 3D organoids and their genetic manipulation. Nat Protoc. 2016;11(9):1724-1743.
Google Scholar | Crossref | Medline33. Pavia-Jimenez, A, Tcheuyap, VT, Brugarolas, J. Establishing a human renal cell carcinoma tumorgraft platform for preclinical drug testing. Nat Protoc. 2014;9(8):1848-1859.
Google Scholar | Crossref | Medline34. Lynch, SV, Pedersen, O. The human intestinal microbiome in health and disease. N Engl J Med. 2016;375(24):2369-2379.
Google Scholar | Crossref | Medline35. Fernandez, M, Reina-Perez, I, Astorga, J, Rodriguez-Carillo, A, Plaza-Diaz, J, Fontana, F. Breast cancer and its relationship with the microbiota. Int J Environ Res Public Health. 2018;15(8):1747.
Google Scholar | Crossref36. Gao, R, Gao, Z, Huang, L, Qin, H. Gut microbiota and colorectal cancer. Eur J Clin Microbiol Infect Dis. 2017;36(5):757-769.
Google Scholar | Crossref | Medline37. Yu, L, Schwabe, R. The gut microbiome and liver cancer: mechanisms and clinical translation. Nat Rev Gastroenterol Hepatol. 2017;14(9):527-539.
Google Scholar | Crossref | Medline38. Wallington, M, Saxon, EB, Bomb, M, et al. 30-day mortality after systemic anticancer treatment for breast and lung cancer in England: a population-based, observational study. Lancet Oncoli. 2016;17(9):1203-1216.
Google Scholar | Crossref | Medline39. Iida, N, Dzutsev, A, Stewart, CA, et al. Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment. Science. 2013;342(6161):967-970.
Google Scholar | Crossref | Medline | ISI40. Lin, XB, Farhangfar, A, Valcheva, R, et al. The role of intestinal microbiota in development of irinotecan toxicity and in toxicity reduction through dietary fibres in rats. PLoS One. 2014;9(1):e83644.
Google Scholar41. Viaud, S, Saccheri, F, Mignot, G, et al. The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide. Science. 2013;342(6161):971-976.
Google Scholar | Crossref | Medline | ISI42. Peters, BA, Dominianni, C, Shapiro, JA, et al. The gut microbiota in conventional and serrated precursors of colorectal cancer. Microbiome. 2016;4(1):69.
Google Scholar | Crossref | Medline43. Luu, TH, Michel, C, Bard, JM, Dravet, F, Nazih, H, Bobin-Dubigeon, C. Intestinal proportion of Blautia sp. is associated with clinical stage and histoprognostic grade in patients with early-stage breast cancer. Nutr Cancer. 2017;69(2):267-275.
Google Scholar | Crossref | Medline44. Xuan, C, Shamonki, JM, Chung, A, et al. Microbial dysbiosis is associated with human breast cancer. PLoS One. 2014;9(1):e83744.
Google Scholar | Crossref45. Pushalkar, S, Hundeyin, M, Daley, D, et al. The pancreatic cancer microbiome promotes oncogenesis by induction of innate and adaptive immune suppression. Cancer Discov. 2018;8(4):403-416.
Google Scholar | Crossref | Medline46. Gillies, RJ, Kinahan, PE, Hricak, H. Radiomics: Images are more than pictures, they are data. Radiology. 2016;278(2):563-577.
Google Scholar | Crossref | Medline47. Hou, L, Singh, K, Samaras, D, Kurc, TM, Seidman, RJ, Saltz, JH. Automatic histopathology image analysis with CNNs. Paper presented at the New York Scientific Data Summit (NYSDS), New York, 2016.
Google Scholar48. Biomarkers Definitions Working Group . Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther. 2001;69(3):89-95.
Google Scholar | Crossref | Medline | ISI49. O’Connor, J, Aboagye, E, Adams, J, et al. Imaging biomarker roadmap for cancer studies. Nat Rev Clin Oncol. 2017;14:169-186.
Google Scholar | Crossref | Medline | ISI50. Xu, F, Quinn, C, Porwal, M, O’Neill, S, Goldstein, D. Can health service utilisation by gastrointestinal cancer patients be assessed using data from a biobank? Poster presented at: Clinical Oncology Society Australia, Perth WA. Asia-Pacific J Clin Oncol. 2018;14(S7):95.
Google Scholar